Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Last Updated: June 8, 2023

CLINICAL TRIALS PROFILE FOR CLONIDINE

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

All Clinical Trials for Clonidine

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00000279 ↗	Novel Medications for Opiate Detoxification - 4	Completed	National Institute on Drug Abuse (NIDA)	Phase 2	1994-09-01	The purpose of this study is to evaluate novel medications for opiate detoxification.
NCT00000279 ↗	Novel Medications for Opiate Detoxification - 4	Completed	VA Connecticut Healthcare System	Phase 2	1994-09-01	The purpose of this study is to evaluate novel medications for opiate detoxification.
NCT00000279 ↗	Novel Medications for Opiate Detoxification - 4	Completed	Yale University	Phase 2	1994-09-01	The purpose of this study is to evaluate novel medications for opiate detoxification.
NCT00000800 ↗	Methadone Effects on Zidovudine (ZDV, AZT) Disposition	Completed	Glaxo Wellcome	Phase 1	1969-12-31	To determine whether methadone maintenance alters the pharmacokinetics of zidovudine (AZT). To determine whether any such effect of methadone on disposition of AZT is time dependent and whether a metabolic interaction between AZT and methadone exists. Injection drug users represent an increasing proportion of HIV-infected persons. Since daily methadone maintenance is the major chemical treatment for injection drug abuse, it is important to determine the impact of methadone on AZT absorption, distribution, and elimination.
NCT00000800 ↗	Methadone Effects on Zidovudine (ZDV, AZT) Disposition	Completed	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1	1969-12-31	To determine whether methadone maintenance alters the pharmacokinetics of zidovudine (AZT). To determine whether any such effect of methadone on disposition of AZT is time dependent and whether a metabolic interaction between AZT and methadone exists. Injection drug users represent an increasing proportion of HIV-infected persons. Since daily methadone maintenance is the major chemical treatment for injection drug abuse, it is important to determine the impact of methadone on AZT absorption, distribution, and elimination.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for Clonidine

Condition Name

Chart
Table

Condition Name for Clonidine
Intervention	Trials
Postoperative Pain	18
Hypertension	15
Pain	14
Pain, Postoperative	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for Clonidine
Intervention	Trials
Pain, Postoperative	40
Delirium	17
Hypertension	15
Opioid-Related Disorders	14
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Clonidine

Trials by Country

Map
Table

Trials by Country for Clonidine
Location	Trials
United States	250
Egypt	43
France	19
Brazil	16
Canada	15
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for Clonidine
Location	Trials
New York	22
Texas	16
Maryland	16
California	15
North Carolina	14
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Clonidine

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for Clonidine
Clinical Trial Phase	Trials
Phase 4	111
Phase 3	52
Phase 2/Phase 3	14
[disabled in preview]	75
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for Clonidine
Clinical Trial Phase	Trials
Completed	196
Recruiting	47
Not yet recruiting	35
[disabled in preview]	58
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Clonidine

Sponsor Name

Chart
Table

Sponsor Name for Clonidine
Sponsor	Trials
National Institute on Drug Abuse (NIDA)	15
Assiut University	15
Cairo University	9
[disabled in preview]	16
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for Clonidine
Sponsor	Trials
Other	492
Industry	40
NIH	32
[disabled in preview]	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson

Moodys

Medtronic

Dow

Boehringer Ingelheim

Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.